HI
Vyome Holdings, Inc. (HIND)
NASDAQ·Healthcare·Biotechnology
$2.13
-0.93%
Mkt Cap $15.01M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | $36.55K | $36.55K | +0.00% | -$0.47 | -$0.47 | +0.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | $34.63K | — | -$0.11 | -$3.12 | -2736.36% | — | — |
| Q3 2025 Aug 14, 2025 | — | $1.24M | — | — | -$2.25 | — | — | — |
| Q2 2025 May 20, 2025 | — | $1.11M | — | — | $18.98 | — | — | — |
| Q2 2025 Apr 4, 2025 | $3.17M | $1.80M | -43.11% | -$101.50 | -$47.25 | +53.45% | — | — |
| Q4 2024 Nov 14, 2024 | $2.51M | $2.29M | -8.61% | -$5.80 | -$3.11 | +46.38% | — | — |
| Q3 2024 Aug 14, 2024 | $2.21M | $1.97M | -11.09% | -$6.96 | -$3.49 | +49.86% | — | — |
| Q2 2024 May 15, 2024 | $2.10M | $1.94M | -7.43% | -$0.16 | -$5.23 | -3168.75% | — | — |
| Q1 2024 Feb 23, 2024 | — | $1.98M | — | -$0.18 | -$0.11 | +38.89% | — | — |
| Q4 2023 Nov 8, 2023 | $2.21M | $2.15M | -2.49% | -$1.20 | -$59.30 | -4841.67% | — | — |
| Q3 2023 Aug 7, 2023 | $2.40M | $2.25M | -6.08% | -$1.79 | -$62.79 | -3407.82% | — | — |
| Q2 2023 May 15, 2023 | $2.51M | $2.29M | -8.88% | -$4.21 | -$90.70 | -2054.39% | — | — |
| Q1 2023 Mar 29, 2023 | $3.10M | $3.11M | +0.32% | -$10.00 | -$8.59 | +14.10% | — | — |
| Q4 2022 Nov 14, 2022 | $3.62M | $2.80M | -22.64% | -$17.75 | -$552.33 | -3011.72% | — | — |
| Q3 2022 Aug 19, 2022 | $3.41M | $2.89M | -15.15% | -$18.00 | -$1191.86 | -6521.44% | — | — |
| Q2 2022 May 23, 2022 | $3.22M | $2.44M | -24.28% | -$17.00 | -$1104.65 | -6397.94% | — | — |
| Q1 2022 Mar 28, 2022 | $3.74M | $3.14M | -15.98% | -$8.50 | $145.35 | +1810.00% | — | — |
| Q4 2021 Nov 11, 2021 | — | $3.71M | — | -$7.50 | -$901.16 | -11915.47% | — | — |
| Q3 2021 Aug 16, 2021 | — | $3.53M | — | — | -$436.05 | — | — | — |
| Q2 2021 May 12, 2021 | $2.19M | $3.22M | +47.22% | -$26.50 | -$3837.59 | -14381.47% | — | — |